ft.com | UK Follow AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug Drugmaker’s largest deal in more than half a decade comes amid surge of M&A in sector https://www.ft.com/content/42b5d5d0-0797-43eb-920c-120f68d21f0a ft.com
